Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Relay Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of RLAY: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders2084199−5
Shares171.0M1.06M166.2M−3.73M (−2.2%)
Value$591.8M$3.66M$867.4M+$279.3M (+47.5%)

4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (20)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to RLAY in Q3 2025
InstitutionSharesValue% of portfolio
TCG Crossover Management, LLC1,810,351$9.45M0.46%
Balyasny Asset Management LLC1,174,971$6.13M0.01%
Jane Street Group, LLC184,951$965.4K0.00%
State of Wisconsin Investment Board81,384$424.8K0.00%
Tudor Investment Corp Et Al76,446$399.0K0.00%
Brevan Howard Capital Management LP61,629$321.7K0.00%
Mayport, LLC49,681$259.3K0.06%
SRS Capital Advisors, Inc.15,057$78.6K0.00%
CIBC Bancorp USA Inc.14,116$73.7K0.00%
49 Wealth Management, LLC13,101$68.4K0.01%
Mercer Global Advisors Inc13,055$68.1K0.00%
Quantinno Capital Management LP12,373$64.6K0.00%
Abel Hall, LLC11,175$58.3K0.02%
Hager Investment Management Services, LLC2,178$11.4K0.01%
Optiver Holding B.V.1,228$6.41K0.00%
Umb Bank N A735$3.84K0.00%
Parkside Financial Bank & Trust129$6740.00%
Advisory Services Network, LLC81$4230.00%
Sunbelt Securities, Inc.52$2710.00%
Transamerica Financial Advisors, Inc.13$680.00%

Sold out (25)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of RLAY in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Ameriprise Financial Inc410,896$1.42M
HarbourVest Partners LLC296,402$1.03M
Verition Fund Management LLC290,599$1.01M
XTX Topco Ltd241,230$834.7K
ExodusPoint Capital Management, LP170,196$589.0K
UBS Oconnor LLC127,036$439.5K
Squarepoint Ops LLC87,551$302.9K
OP Asset Management Ltd70,542$244.1K
Sanctuary Advisors, LLC58,654$202.9K
Marshall Wace, LLP51,698$178.9K
TrueMark Investments, LLC49,628$171.7K
Jain Global LLC39,770$137.6K
Engineers Gate Manager LP38,719$134.0K
Arkadios Wealth Advisors25,635$88.7K
111 Capital24,911$86.2K
Alpine Global Management, LLC23,851$82.5K
Colony Group, LLC19,647$68.0K
Zacks Investment Management15,307$53.0K
Jump Financial, LLC15,301$52.9K
Quadrature Capital Ltd13,496$46.8K
Catalyst Funds Management Pty Ltd11,500$39.8K
May Hill Capital, LLC10,914$37.8K
HighTower Advisors, LLC10,320$35.7K
Highline Wealth Partners LLC5,000$17.3K
Simplex Trading, LLC2,984$10.0K

Not filed for Q3 2025 yet (4)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Norges Bank835,874$2.89M
Congress Wealth Management LLC186,063$643.8K
E Fund Management Co., Ltd.20,258$70.1K
CIBC World Markets Corp16,316$56.5K